Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Nutra Pharma's price to sales ratio was 4.5× on Oct 19, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 0.0× to 277.5×, with a median of 3.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 4.5× | +2.2 |
| 2025 | Dec 31, 2025 | 2.3× | −1.1 |
| 2024 | Dec 31, 2024 | 3.4× | +0.4 |
| 2023 | Dec 29, 2023 | 3.0× | −5.2 |
| 2022 | Dec 30, 2022 | 8.2× | −160.0 |
| 2021 | Dec 31, 2021 | 168.2× | −1.8 |
| 2020 | Dec 31, 2020 | 170.0× | +148.8 |
| 2019 | Dec 31, 2019 | 21.2× | +12.5 |
| 2018 | Dec 31, 2018 | 8.7× | +1.5 |
| 2017 | Dec 29, 2017 | 7.2× | +3.1 |
| 2016 | Dec 30, 2016 | 4.1× | −1.8 |
| 2015 | Dec 31, 2015 | 6.0× | −6.7 |
| 2014 | Dec 31, 2014 | 12.7× | −16.2 |
| 2013 | Dec 31, 2013 | 28.8× | +20.0 |
| 2012 | Jan 31, 2012 | 8.8× | −2.9 |
| 2011 | Dec 30, 2011 | 11.7× | – |
See a number that looks wrong?